Dietary red palm oil protects the heart against the cytotoxic effects of anthracycline

Cell Biochemistry and Function

Volumn 29, Issue 5, 2011, Pages 356-364

  Wergeland, A ^a   Bester, D J ^b   Sishi, B J N ^c   Engelbrecht, A M ^c   Jonassen, A K ^a   Van Rooyen, J ^b  

^a UNIVERSITY OF BERGEN   (Norway)

^b CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Antioxidant; Antracyclines; Cardiotoxicity; Daunorubicin; Dietary supplementation

Indexed keywords

ANTHRACYCLINE; COPPER ZINC SUPEROXIDE DISMUTASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; NEURONAL NITRIC OXIDE SYNTHASE; PALM OIL; RED PALM OIL; SODIUM CHLORIDE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CARDIOTOXICITY; CELLULAR STRESS SIGNAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; HEART FUNCTION; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING;

ANIMALS; ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; AORTA; DAUNORUBICIN; DIETARY SUPPLEMENTS; HEART; HEART FUNCTION TESTS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE SYNTHASE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLANT OILS; PROTECTIVE AGENTS; RATS; RATS, WISTAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 79960087109     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1756     Document Type: Article

References (49)

1. Arcamone F, Cassinelli G, Fantini G, et al. Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius. Biotechnol Bioeng 1969; 11(6): 1101-1110.
2. Chua CC, Liu X, Gao J, Hamdy RC, Chua BH. Multiple actions of pifithrin-alpha on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells. Am J Physiol Heart Circ Physiol 2006; 290(6): H2606-H2613.
3. d'Anglemont de Tassigny A, Berdeaux A, Souktani R, Henry P, Ghaleh B. The volume-sensitive chloride channel inhibitors prevent both contractile dysfunction and apoptosis induced by doxorubicin through PI3kinase, Akt and Erk 1/2. Eur J Heart Fail 2008; 10(1): 39-46.
4. Deng S, Kulle B, Hosseini M, et al. Dystrophin-deficiency increases the susceptibility to doxorubicin-induced cardiotoxicity. Eur J Heart Fail 2007; 9(10): 986-994.
5. Engelbrecht AM, Esterhuyse J, du Toit EF, Lochner A, van Rooyen J. p38-MAPK and PKB/Akt, possible role players in red palm oil-induced protection of the isolated perfused rat heart? J Nutr Biochem 2006; 17(4): 265-271.
6. Esterhuyse AJ, du Toit EF, Benade AJ, van Rooyen J. Dietary red palm oil improves reperfusion cardiac function in the isolated perfused rat heart of animals fed a high cholesterol diet. Prostaglandins Leukot Essent Fatty Acids 2005; 72(3): 153-161.
7. Esterhuyse JS, Van Rooyen J, Strijdom H, Bester D, Du Toit EF. Proposed mechanisms for red palm oil induced cardioprotection in a model of hyperlipidaemia in the rat. Prostaglandins Leukot Essent Fatty Acids 2006; 75: 375-384.
8. Ferdinandy P, Schultz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 2003; 138: 532-543.
9. Frias MA, Somers S, Gerber-Wicht C, Opie LH, Lecour S, Lang U. The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis. Cardiovasc Res 2008; 80(1): 69-77.
10. Gausdal G, Gjertsen BT, McCormack E, et al. Abolition of stress-induced protein synthesis sensitizes leukaemia cells to anthracycline-induced death. Blood 2008; 111(5): 2866-2877.
11. Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, Sawyer DB. Anthracycline cardiotoxicity: from bench to bedside. J Clin Oncol 2008; 26(22): 3777-3784.
12. Giricz Z, Csonka C, Onody A, Csont T, Ferdinandy P. Role of cholesterol-enriched diet and the mevalonate pathway in cardiac nitric oxide synthesis. Basic Res Cardiol 2003; 98: 304-310.
13. Goormaghtigh E, Huart P, Praet M, Brasseur R, Ruysschaert JM. Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity. Biophys Chem 1990; 35(2-3): 247-257.
14. Han X, Pan J, Ren D, Cheng Y, Fan P, Lou H. Naringenin-7-O-glucoside protects against doxorubicin-induced toxicity in H9c2 cardiomyocytes by induction of endogenous antioxidant enzymes. Food Chem Toxicol 2008; 46(9): 3140-3146.
15. Hassan HM, Fridovich I. Chemistry and biochemistry of superoxide dismutses. Eur J Rheumatol Inflamm 1981; 4(2): 160-172.
16. Johnson BA, Cheang MS, Goldenberg GJ. Comparison of adriamycin uptake in chick embryo heart and liver cells an murine L5178Y lymphoblasts in vitro: role of drug uptake in cardiotoxicity. Cancer Res 1986; 46(1): 218-223.
17. Kalender S, Kalender Y, Ates A, Yel M, Olcay E, Candan S. Protective role of antioxidant vitamin E and catechin on idarubicin-induced cardiotixicity in rats. Braz J Med Biol Res 2002; 35(11): 1379-1387.
18. Kang YJ, Chen Y, Epstein PN. Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J Biol Chem 1996; 271(21): 12610-12616.
19. Kang YJ, Zhou ZX, Wang GW, Buridi A, Klein JB. Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases. J Biol Chem 2000; 275(18): 13690-13698.
20. Kruger MJ, Engelbrecht AM, Esterhuyse J, du Toit EF, van Rooyen J. Dietary red palm oil reduces ischaemia-reperfusion injury in rats fed a hypercholesterolaemic diet. Br J Nutr 2007; 97(4): 653-660.
21. Li L, Takemura G, Li Y, et al. Granulocyte colony-stimulating factor improves left ventricular function of doxorubicin-induced cardiomyopathy. Lab Invest 2007; 87(5): 440-455.
22. Liu J, Mao W, Ding B, Liang CS. ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. Am J Physiol Heart Circ Physiol 2008; 295(5): H1956-H1965.
23. Lou H, Danelisen I, Singal PK. Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy. Am J Physiol Heart Circ Physiol 2005; 288(4): H1925-30.
24. Maulik N, Watanabe M, Zu YL, et al. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 1996; 396: 233-237.
25. Myers CE, McGuire W, Young R. Adriamycin: amelioration of toxicity by alpha-tocopherol. Cancer Treat Rep 1976; 60(7): 961-962.
26. Onody A, Csonka C, Giricz Z, Ferdinandy P. Hyperlipidaemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts. Cardiovasc Res 2003; 58: 663-670.
27. Perkins WE, Schroeder RL, Carrano RA, Imondi AR. Effect of ICRF-187 on doxorubicin-induced myocardial effects in the mouse and guinea pig. Br J Cancer 1982; 46(4): 662-667.
28. Poizat C, Puri PL, Bai Y, Kedes L. Phosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells. Mol Cell Biol 2005; 25(7): 2673-2687.
29. Serbinova E, Khavaja S, Catudioc J, et al. Palm oil vitamin E protects against ischemia/reperfusion injury in the isolated perfused Langendorff heart. Nutr Res 1992; 12: S203-S215.
30. Shioji K, Kishimoto C, Nakamura H, et al. Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Circulation 2002; 106(11): 1403-1409.
31. Stahl W, Sies H. Bioactivity and protective effects of natural carotenoids. Biochim Biophys Acta 2005; 1740: 101-107.
32. Su HF, Samsamshariat A, Fu J, et al. Oleylethanolamide activates Ras-Erk pathway and improves myocardial function in doxorubicin-induced heart failure. Endocrinology 2006; 147(2): 827-834.
33. Sun X, Zhou Z, Kang YJ. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart. Cancer Res 2001; 61(8): 3382-3387.
34. Sundram K, Sambanthamurthi R, Tan YA. Palm fruit chemistry and nutrition. Asia Pac J Clin Nutr 2003; 12(3): 355-362.
35. Swain SM, Whaley FS, Gerber MC, Ewer MS, Bianchine JR, Gams RA. Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy. J Clin Oncol 1997; 15(4): 1333-1340.
36. Tan C, Tasaka H, Yu KP, Murphy ML, Karnofsky DA. Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. Cancer 1967; 20(3): 333-353.
37. Tesoriere L, Ciaccio M, Valenza M, et al. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality. J Pharmacol Exp Ther 1994; 269(1): 430-436.
38. Thabrew MI, Samarawickrema N, Chandrasena LG, Jayasekera S. Effect of oral supplementation with vitamin E on the oxido-reductive status of red blood cells in normal mice and mice subject to oxidative stress by chronic administration of adriamycin. Ann Clin Biochem 1999; 36 (Pt 2): 216-220.
39. Tokarska-Schlattner M, Zaugg M, Zuppinger C, Wallimann T, Schlattner U. New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics. J Mol Cell Cardiol 2006; 41(3): 389-405.
40. van Rooyen J, Esterhuyse AJ, Engelbrecht AM, Du Toit EF. Health benefits of a natural carotenoid rich oil: a proposed mechanism of protection against ischaemia/reperfusion injury. Asia Pac J Clin Nutr 2008; 17(S1): 316-319.
41. Vile GF, Winterbourn CC. Inhibition of adriamycin-promoted microsomal lipid peroxidation by beta-carotene, alpha-tocopherol and retinol at high and low oxygen partial pressures. FEBS Lett 1988; 238(2): 353-356.
42. Von Hoff DD, Rozencweig M, Layard M, Slavik M, Muggia FM. Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases. Am J Med 1977; 62(2): 200-208.
43. Von Hoff DD, Layard MW, Basa P, et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 1979; 91(5): 710-717.
44. Wahab MH, Akoul ES, Abdel-Aziz AA. Modulatory effects of melatonin and vitamin E on doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma-bearing mice. Tumori 2000; 86(2): 157-162.
45. Weinbrenner C, Liu GS, Cohen MV, Downey JM. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol 1997; 29: 2383-2391.
46. Weiss RB. The anthracyclines: will we ever find a better doxorubicin? Semin Oncol 1992; 19(6): 670-686.
47. Xiang P, Deng HY, Li K, et al. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model. Cancer Chemother Pharmacol 2009; 63(2): 343-349.
48. Yen HC, Oberley TD, Vichitbandha S, Ho YS, St Clair DK. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest 1996; 98(5): 1253-1260.
49. Zhu W, Zou Y, Aikawa R, et al. MAPK superfamily plays an important role in daunomycin-induced apoptosis of cardiac myocytes. Circulation 1999; 100(20): 2100-2107.